BXLT, KMDA ink clinical-trial collaboration to test AAT for prevention of lung-transplant rejection: http://finance.yahoo.com/news/kamada-collaborates-baxalta-phase-1-103000657.html p.s. BXLT, which will be formally spun off from BAX on 7/1/15, is now trading on a “when issued” basis (http://finance.yahoo.com/q?s=BXLT-WI&ql=0 ).